Gene · 4440
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histologic Evidence of Oral and Periodontal Regeneration Using Recombinant Human Platelet-Derived Growth Factor. | Medicina (Kaunas) | 2023 | 37109634 | PubTator, text mining | PubMed |
| Clinical Significance of Cancer Stem Cell Markers in Primary and Metastatic Tissues in Patients With Breast Cancer. | Anticancer Res | 2023 | 37097684 | PubTator, text mining | PubMed |
| The most likely but largely ignored triggering factor for breast (or all) cancer invasion. | J Cancer | 2023 | 37057291 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1. | Inflamm Regen | 2023 | 37009886 | PubTator, text mining | PubMed |
| Epitranscriptomics in the development, functions, and disorders of cancer stem cells. | Front Oncol | 2023 | 37007137 | PubTator, text mining | PubMed |
| Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy. | J Transl Med | 2023 | 37004094 | PubTator, text mining | PubMed |
| Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow. | Aging (Albany NY) | 2023 | 36996499 | PubTator, text mining | PubMed |
| Exosomal Circ_FMN2 Derived from the Serum of Colorectal Cancer Patients Promotes Cancer Progression by miR-338-3p/MSI1 Axis. | Appl Biochem Biotechnol | 2023 | 36995659 | PubTator, text mining | PubMed |
| The dark side of mRNA translation and the translation machinery in glioblastoma. | Front Cell Dev Biol | 2023 | 36994107 | PubTator, text mining | PubMed |
| REST/NRSF Silencing Modifies Neuronal Gene Expression in siRNA-Treated HeLa Cells: A Preliminary Exploration in the Search for Neuronal Biomarkers of Cervical Cancer. | Medicina (Kaunas) | 2023 | 36984538 | PubTator, text mining | PubMed |
| Predicting Key Genes and Therapeutic Molecular Modelling to Explain the Association between Porphyromonas gingivalis (P. gingivalis) and Alzheimer's Disease (AD). | Int J Mol Sci | 2023 | 36982508 | PubTator, text mining | PubMed |
| Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas. | Int J Mol Sci | 2023 | 36982406 | PubTator, text mining | PubMed |
| Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy. | Front Immunol | 2023 | 36969167 | PubTator, text mining | PubMed |
| Biological functions, mechanisms, and clinical significance of circular RNA in colorectal cancer. | Front Oncol | 2023 | 36950552 | PubTator, text mining | PubMed |
| LIN28 and histone H3K4 methylase induce TLR4 to generate tumor-initiating stem-like cells. | iScience | 2023 | 36949755 | PubTator, text mining | PubMed |
| Matrin3 regulates mitotic spindle dynamics by controlling alternative splicing of CDC14B. | Cell Rep | 2023 | 36924503 | PubTator, text mining | PubMed |
| Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity. | Nat Rev Mol Cell Biol | 2023 | 36922629 | PubTator, text mining | PubMed |
| Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract. | Cancers (Basel) | 2023 | 36900417 | PubTator, text mining | PubMed |
| MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review. | Cancers (Basel) | 2023 | 36900159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4440/papers?page=9